Sakopoulos A G, Hahn T L, Turrentine M, Brown J W
Department of Surgery, Riley Children's Hospital, Indiana University, Indianapolis, USA.
J Thorac Cardiovasc Surg. 1998 Oct;116(4):560-5. doi: 10.1016/S0022-5223(98)70161-8.
We reviewed our experience with surgical repair compared with balloon aortoplasty of recurrent coarctations of the aorta.
This is a retrospective review of 1 institution's 27-year experience with surgical repair of recurrent aortic coarctation. A thorough chart review was performed of all pediatric patients undergoing surgical repair for recurrent aortic coarctation (n = 56) from January 1970 through July 1996.
The vast majority of recoarctations were repaired with a prosthetic patch technique, with a greater than 96% success rate. No deaths or major complications occurred in the 56 patients. Although a direct comparison with balloon aortoplasty cannot be done, we have reviewed the data available in the literature and found higher complication rates and lower success rates than we obtained in our series.
Although the treatment of aortic coarctation has improved significantly during the past decades, persistent hypertension after repairs at an older age and recurrent coarctation after repairs in neonates occur in all institutions. Surgeons have not agreed on the optimal approach to primary coarctation repair, and invasive cardiologists have challenged operative intervention for both recurrent and primary coarctation. This study demonstrates that surgical repair of recurrent coarctation of the aorta can be performed safely and with excellent results. We believe it is still the gold standard in the management of recurrent coarctation of the aorta.
我们回顾了与主动脉缩窄复发的球囊主动脉成形术相比,手术修复的经验。
这是对一家机构27年主动脉缩窄复发手术修复经验的回顾性研究。对1970年1月至1996年7月期间接受复发性主动脉缩窄手术修复的所有儿科患者(n = 56)进行了全面的病历审查。
绝大多数再缩窄采用人工补片技术修复,成功率超过96%。56例患者中无死亡或重大并发症发生。虽然无法与球囊主动脉成形术进行直接比较,但我们查阅了文献中的可用数据,发现其并发症发生率更高,成功率更低。
尽管在过去几十年中主动脉缩窄的治疗有了显著改善,但所有机构都存在大龄修复后持续高血压以及新生儿修复后再缩窄的情况。外科医生对于原发性缩窄修复的最佳方法尚未达成共识,而介入心脏病专家对复发性和原发性缩窄的手术干预提出了质疑。本研究表明,主动脉缩窄复发的手术修复可以安全进行且效果良好。我们认为它仍然是主动脉缩窄复发治疗的金标准。